The medical community continues to seek treatments for covid-19.
The use of plasma from convalescent patients dates back more than a hundred years, according to information from the National Center for Biotechnology Information (NCBI) in the United States.
Now, its use in covid-19 patients is being studied.
Infectious disease specialist Dr. Edward Cachay, who is part of a team investigating its use, explains the details.